To provide some potential mechanistic insights into the relationship between high BAG-1 expression and improved outcome in ER+ tamoxifen-treated patients, we assessed the effect of BAG-1 overexpression on oestrogen/antioestrogen sensitivity in ER+ MCF-7 breast cancer cells. The gene discussed is BAG1; the disease is breast cancer.